Latest Conference Articles

Broader Genetic Testing Can Save Costs, Determine Treatment Plans in Lung Cancer

Broader Genetic Testing Can Save Costs, Determine Treatment Plans in Lung Cancer

June 1st 2018, 7:31pm

ASCO Annual Meeting

Using next-generation sequencing (NGS) to test patients with non-small cell lung cancer (NSCLC) for all known genetic mutations associated with the disease appeared to be faster and more cost-effective than testing for one gene at a time – not to mention the results could have treatment implications.

Genetic Counseling With Telemedicine Helps Patients in Community Practices

Genetic Counseling With Telemedicine Helps Patients in Community Practices

June 1st 2018, 5:13pm

ASCO Annual Meeting

Patients who would otherwise not have access to genetic counseling at community-based medical centers can benefit from the use of remote phone or video technology to take advantage of these services, according to study results presented at the American Society of Clinical Oncology Annual Meeting in Chicago on June 1-4.

Cognitive Behavioral Therapy and Acupuncture Can Help Survivors With Insomnia Rest Assured

Cognitive Behavioral Therapy and Acupuncture Can Help Survivors With Insomnia Rest Assured

May 30th 2018, 7:47pm

ASCO Annual Meeting

Insomnia is a common issue that many patients and survivors face. However, cognitive behavioral therapy and acupuncture was proven to be helpful in a recent study.

Survivor Helps Women Go Through Ovarian Cancer with Grace

Survivor Helps Women Go Through Ovarian Cancer with Grace

April 29th 2018, 4:00pm

National Ovarian Cancer Coalition National Conference

Sherry Pollex, founder of SherryStrong.com, offered women a variety of ways to lead a healthier lifestyle during treatment, and an array of hope to go through their journeys with joy and thanks.

Mother-Son Duo Gets Passionate About Ovarian Cancer Awareness

Mother-Son Duo Gets Passionate About Ovarian Cancer Awareness

April 28th 2018, 10:47pm

National Ovarian Cancer Coalition National Conference

Ryan Mitstifer is not like most 15-year-old boys. This weekend, while others may have been found hanging out with friends or catching up on schoolwork, Ryan is out spreading the word about ovarian cancer.

Ovarian Cancer Dream Team Helps With Genetic Testing Process

Ovarian Cancer Dream Team Helps With Genetic Testing Process

April 28th 2018, 10:40pm

National Ovarian Cancer Coalition National Conference

Stephanie V. Blank, M.D., talks about the MAGENTA study, designed to ease the time-consuming process for which women undergo genetic testing.

Genetic Testing, Treatment Advances Offer 'Hope on the Horizon' for Ovarian Cancer

Genetic Testing, Treatment Advances Offer 'Hope on the Horizon' for Ovarian Cancer

April 28th 2018, 10:31pm

National Ovarian Cancer Coalition National Conference

During the 2018 National Ovarian Cancer Coalition, Angeles Alvarez Secord, M.D., MHSc highlighted the importance of genetic testing and its impact on treatment options for women with ovarian cancer.

What Gives Patients and Loved Ones Hope?

What Gives Patients and Loved Ones Hope?

April 28th 2018, 8:00pm

National Ovarian Cancer Coalition National Conference

It is important that patients and their loved ones stay hopeful during the ovarian cancer journey. We asked attendees of the 2018 NOCC Annual Conference how they keep positive.

Ovarian Cancer Expert Offers Hope Against 'Silent Killer' Stereotype

Ovarian Cancer Expert Offers Hope Against 'Silent Killer' Stereotype

April 28th 2018, 1:51am

National Ovarian Cancer Coalition National Conference

CURE sat down with Richard Boulay, M.D., at the 2018 National Ovarian Cancer Coalition to discuss exciting updates in ovarian cancer, as well as what advice he would offer to patients and caregivers who may be feeling overwhelmed.

Preventing Opioid Addiction in Patients With Cancer

Preventing Opioid Addiction in Patients With Cancer

March 28th 2018, 7:57pm

SGO Annual Meeting on Women's Cancer

Jaron Mark, M.D., a gynecologic oncology fellow at Roswell Park Comprehensive Cancer Center, discusses the opioid crisis, and the steps that his institution is taking to combat potential addiction in women who undergo surgery for gynecologic cancer.

Ask an Expert: How Do PARP Inhibitors Work?

Ask an Expert: How Do PARP Inhibitors Work?

March 27th 2018, 7:41pm

SGO Annual Meeting on Women's Cancer

PARP inhibitors are generating a lot of excitement in the field of ovarian cancer. But how, exactly, do they work? CURE spoke with one expert to find out.

Gene Testing Can Help Improve Ovarian Cancer Care and Decision Making

Gene Testing Can Help Improve Ovarian Cancer Care and Decision Making

March 26th 2018, 10:02pm

SGO Annual Meeting on Women's Cancer

Knowing which kind of therapy works best can help in determining the ideal cancer care for patients.

Checkpoint Inhibitors Induce Response, Higher Rates of Side Effects

Checkpoint Inhibitors Induce Response, Higher Rates of Side Effects

March 26th 2018, 5:17pm

SGO Annual Meeting on Women's Cancer

“There has been a rapid expansion in the use of checkpoint inhibition in many solid tumor types,” lead author Emily Hinchcliff, M.D.

Four Individuals Named Ovarian Cancer Heroes at Inaugural Event

Four Individuals Named Ovarian Cancer Heroes at Inaugural Event

March 24th 2018, 4:29pm

SGO Annual Meeting on Women's Cancer

At the inaugural Ovarian Cancer Heroes gala, held in New Orleans ahead of the 49th Society of Gynecologic Oncology Annual Meeting on Women’s Cancers, four individuals — a physician, nurse navigator and two patient-turned-advocates — were awarded for the contributions they have made to increase awareness and advance research and education for ovarian cancer.

Postmenopausal Women Who Lose Weight May Have Reduced Breast Cancer Risk

Postmenopausal Women Who Lose Weight May Have Reduced Breast Cancer Risk

December 9th 2017, 1:11am

SABCS

Losing even a moderate amount of extra weight significantly reduces the risk of breast cancer for postmenopausal women, a researcher reports.

Oropharyngeal Cancer Risks Include Number of Sexual Partners, Smoking

Oropharyngeal Cancer Risks Include Number of Sexual Partners, Smoking

December 9th 2017, 12:52am

SABCS

The incidence of human papillomavirus-related oropharyngeal cancer (HPV-OPC) is on the rise. Researchers at Johns Hopkins University assessed survey data to determine whether the risk among the general population is rising as well. Results show that for most people, the risk remains low.

Talazoparib Beats Chemo in BRCA-Positive Breast Cancer

Talazoparib Beats Chemo in BRCA-Positive Breast Cancer

December 9th 2017, 12:30am

SABCS

Talazoparib, a PARP inhibitor is more effective than chemotherapy in reducing the risk of disease progression and death from BRCA-positive breast cancer.

Duration of Arimidex Treatment For Breast Cancer May Safely Be Shortened

Duration of Arimidex Treatment For Breast Cancer May Safely Be Shortened

December 8th 2017, 3:00am

SABCS

Researchers find that women with postmenopausal hormone receptor (HR)-positive breast cancer may undergo shorter treatments of Arimidex, which may in turn cause less bone fractures.

How Many Weeks of Adjuvant Herceptin Is Optimal for People with HER2-Positive Breast Cancer?

How Many Weeks of Adjuvant Herceptin Is Optimal for People with HER2-Positive Breast Cancer?

December 8th 2017, 1:50am

SABCS

A phase 3 clinical trial pitted a nine-week treatment of adjuvant Herceptin against the regimen of a full year of treatment for patients with HER2-positive breast cancer. Results show that the standard treatment of one year is still optimal.

Acupuncture Reduces AI-Associated Joint Pain in Women with Breast Cancer

Acupuncture Reduces AI-Associated Joint Pain in Women with Breast Cancer

December 7th 2017, 11:49pm

SABCS

To address compliance issues associated with treatment using aromatase inhibitors, researchers show that acupuncture effectively eases joint pain, a side effect from hormone therapy.

Controversial Breast Cancer Treatment Strategy May Protect Ovarian Function, Preserve Fertility

Controversial Breast Cancer Treatment Strategy May Protect Ovarian Function, Preserve Fertility

December 7th 2017, 10:36pm

SABCS

A reveiw of five clinical trial findings suggests that gonadotropin-releasing hormone analog has the potential to preserve ovarian function and fertility in premenopausal breast cancer patients.

Kisqali Extends Progression-Free Survival for Premenopausal Breast Cancer Subsets

Kisqali Extends Progression-Free Survival for Premenopausal Breast Cancer Subsets

December 7th 2017, 8:17pm

SABCS

New research demonstrates that a CDK4/6 inhibitor, used in combination with standard endocrine therapy with temporary ovarian suppression significantly improves progression-free survival in younger patients who currently have few treatment options.

Combination Regimen Shows Activity In HER2-Positive Breast Cancer

Combination Regimen Shows Activity In HER2-Positive Breast Cancer

December 7th 2017, 3:30am

SABCS

The combination of Keytruda (pembrolizumab) and Herceptin (trastuzumab) showed promise for the treatment of women with Herceptin-resistant, PD-L1–positive, HER2-positive breast cancer.

Antibody-Drug Conjugate Improves Responses in Metastatic Triple-Negative Breast Cancer

Antibody-Drug Conjugate Improves Responses in Metastatic Triple-Negative Breast Cancer

December 7th 2017, 1:55am

SABCS

A stud presented at SABCS shows that IMMU-132, an antibody-drug conjugate, improves outcomes in women with heavily pretreated metastatic triple-negative breast cancer.

Negative Findings Show Herceptin Fails to Benefit Breast Cancer Subgroup

Negative Findings Show Herceptin Fails to Benefit Breast Cancer Subgroup

December 7th 2017, 12:52am

SABCS

The combination use of Herceptin plus standard adjuvant chemotherapy does not improve outcomes in women with HER2-low breast cancer.

Alternative Chemotherapy Dosing Strategies Improve Breast Cancer Outcomes

Alternative Chemotherapy Dosing Strategies Improve Breast Cancer Outcomes

December 6th 2017, 11:52pm

SABCS

For women with early-stage breast cancer who are receiving chemotherapy, shortening the time between treatment cycles or administering the agents sequentially may reduce disease recurrence and mortality compared with standard chemotherapy regimens.

Novel Therapy Combinations Are Needed for Melanoma Treatment

Novel Therapy Combinations Are Needed for Melanoma Treatment

October 23rd 2017, 7:26pm

World Congress on Melanoma

Research into combination approaches now focuses on using three anti–PD-1 therapies and new checkpoints, such as IDO.

Immunotherapy Combination Sparks a Response in Melanoma Brain Metastases

Immunotherapy Combination Sparks a Response in Melanoma Brain Metastases

October 23rd 2017, 7:19pm

World Congress on Melanoma

The combination of the immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) sparked a response in nearly half of asymptomatic patients with melanoma brain metastases who had not received prior local therapy to the brain.

New Immunotherapy Shows Response for Metastatic Melanoma, Study Says

New Immunotherapy Shows Response for Metastatic Melanoma, Study Says

October 23rd 2017, 7:00pm

World Congress on Melanoma

The longest response rate lasted six months.

Immunotherapy Offers New Optimism for Patients With Merkel Cell Carcinoma

Immunotherapy Offers New Optimism for Patients With Merkel Cell Carcinoma

October 20th 2017, 10:41pm

World Congress on Melanoma

Although chemotherapy has been used to treat patients with Merkel cell carcinoma, immunotherapy agents show great promise, according to findings presented at the 2017 World Congress of Melanoma.